Govt approves Incepta’s Tocilizumab Covid drug
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Saturday
August 13, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
SATURDAY, AUGUST 13, 2022
Govt approves Incepta’s Tocilizumab Covid drug

Health

TBS Report
29 January, 2022, 05:45 pm
Last modified: 29 January, 2022, 09:14 pm

Related News

  • Hacker offers to sell data of 48.5 mln users of Shanghai's Covid app
  • Delhi to enforce mask mandate again after spurt in Covid cases
  • US CDC no longer recommends students quarantine for Covid-19 exposure
  • Flush with wins, finally Covid-free, Biden to hit the road ahead of US midterms
  • Global Covid deaths drop by 9%, Omicron subvariant BA.5 remains dominant: WHO

Govt approves Incepta’s Tocilizumab Covid drug

The drug prevents cytokine storms in the body of Covid patients

TBS Report
29 January, 2022, 05:45 pm
Last modified: 29 January, 2022, 09:14 pm
Govt approves Incepta’s Tocilizumab Covid drug

The Directorate General of Drug Administration (DGDA) has given emergency approval of Incepta Pharmaceuticals' Tocilizumab drug, Tolosa 80, a monoclonal antibody to treat Covid-19. 

Tocilizumab is used in the treatment of Covid-19 patients admitted in the Intensive Care Units (ICU) of hospitals, read a press release. 

Covid-19 can become deadly in some patients by causing hyper-inflammation and cytokine storm. Covid-19 can also extensively harm the lungs of patients, increasing the risk of death.

The drug prevents cytokine storms in the body of Covid patients in critical conditions, decreasing death risk. 

Both the United States Food and Drug Administration (US FDA) and World Health Organisation (Who) have given Tocilizumab emergency use authorisation for the treatment of Covid-19. 

Globally, only one multinational company markets this product. Incepta is the first and only company to launch the biosimilar version of this medicine. Incepta is hopeful that Tolosa will be able to meet the unmet demand of the market.

Incepta pharmaceuticals / COVID-19 / Drug

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The U.S. dollar over the globe.. DANIELE DAILLOUX/GAMMA-RAPHO VIA GETTY IMAGES
    The world is seeing how the dollar really works
  • TBS file image
    There are ways to lessen the burden of fuel price hike. Countries show how
  • BFIU sought illegal money information from Swiss banks repeatedly: BB
    BFIU sought illegal money information from Swiss banks repeatedly: BB

MOST VIEWED

  • File Photo of Health Minister Zahid Maleque.
    Yearly health checkups in govt hospitals from next year: Health minister 
  • Photo: Collected
    No death from Covid-19 in 24 hours
  • Photo: Collected
    2 Covid deaths, 218 cases reported in 24hrs
  • Representational image. Picture: Pixabay
    Saudi King's charity organisation launches medical scheme to combat blindness in Bangladesh
  • Dhaka Medical College Hospital (DMCH) File photo
    DMCH interns go on strike
  • Photo: Rajib Dhar/TBS
    Children 5-11 in age get first Covid vaccine shot

Related News

  • Hacker offers to sell data of 48.5 mln users of Shanghai's Covid app
  • Delhi to enforce mask mandate again after spurt in Covid cases
  • US CDC no longer recommends students quarantine for Covid-19 exposure
  • Flush with wins, finally Covid-free, Biden to hit the road ahead of US midterms
  • Global Covid deaths drop by 9%, Omicron subvariant BA.5 remains dominant: WHO

Features

Toes and talons of Shikra. Photo; Enam Ul Haque

Shikra: A leopard with wings!

7h | Panorama
Photo: Noor-A-Alam

Around the world in 10 days: A chance to taste global cuisines

5h | Food
Lobbyists float ludicrous arguments to prevent tobacco control act amendment

Lobbyists float ludicrous arguments to prevent tobacco control act amendment

8h | Panorama
Will US-China tensions boil over?

Will US-China tensions boil over?

6h | Panorama

More Videos from TBS

What will happen after global warming?

What will happen after global warming?

1h | Videos
Who will clean 'space garbage'?

Who will clean 'space garbage'?

1h | Videos
Photo: TBS

Why you should update your Apple devices and ensure security

6h | Videos
Birds under increasing threat from plastic waste

Birds under increasing threat from plastic waste

6h | Videos

Most Read

1
Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 
Banking

Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 

2
Photo: Collected
Transport

Will Tokyo’s traffic model solve Dhaka’s gridlocks?

3
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

4
Representational Image. Photo: Collected
Bangladesh

Air passengers should plan extra commute time to airport: DMP

5
Arrest warrant against Habib Group chairman, 4 others 
Crime

Arrest warrant against Habib Group chairman, 4 others 

6
File Photo: State Minister for Power, Energy and Mineral Resources Nasrul Hamid
Energy

All factories to remain closed once a week under rationing system

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net